Skip to main content
×
×
Home
  • Print publication year: 2013
  • Online publication date: September 2013

Chapter 38 - Perioperative management of patients with Parkinson's disease

from Section 11 - Neurology
Summary

Introduction and overview of Parkinson's disease

Patients with Parkinson's disease (PD) face surgery more often than their age-matched counterparts due in large part to orthopedic and other injuries provoked by the gait and balance difficulties in advanced stages of the illness. General surgical procedures are at least as common in PD as in their age-matched counterparts, but the perioperative management can be complicated given the nature of the illness and its treatments. Recent advances in neurosurgical techniques and an improved understanding of the pathophysiology of motor symptoms in PD has led to a renewed interest and an increase in the number of patients undergoing various neurosurgical procedures for PD. This chapter provides an overview of the principles and preoperative management of patients with PD and other Parkinsonian states.

Parkinson's disease is an adult-onset neurodegenerative disorder characterized by progressive slowness of movement (bradykinesia), muscular rigidity, stooped posture, tremor, postural instability, and varying degrees of cognitive impairment. It affects close to 1 million Americans, with an annual incidence of 20 new cases per 10,000 and a prevalence of 59–187 cases per 100,000 [1–3]. The median age of onset is 60 years and the mean duration of the disease from diagnosis to death is 15 years [4]. Its pathology is concentrated in the brain and consists of selective degeneration of the nigrostriatal dopaminergic pathway and the presence of alpha synuclein pathology including Lewy bodies and Lewy neurites in surviving mesencephalic dopamine neurons, as well as in other brainstem and cortical neurons [5]. Biochemically, the denervation results in striatal dopamine depletion which is linked to the above signs and symptoms [6]. The cause of selective neuronal death, and therefore the etiology of PD is unknown, although hereditary and environmental factors are thought to play a role.

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Medical Management of the Surgical Patient
  • Online ISBN: 9780511920660
  • Book DOI: https://doi.org/10.1017/CBO9780511920660
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
References
Rajput, AH.Epidemiology of Parkinson's disease. Can J Neurol Sci 1984; 11(1 Suppl): 156–9.
Rajput, AH, Stern, W, Laverty, WH.Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology 1984; 34: 991–6.
Tanner, CM.Epidemiology of Parkinson's disease. Neurologic Clin 1992; 10: 317–27.
Lees, AJ, Hardy, J, Revesz, T.Parkinson's disease. Lancet 2009; 373(9680): 2055–66.
Forno, LS.Pathology of Parkinson's Disease. London: Butterworths; 1982.
Hornykiewicz, O, Kish, SJ.Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987; 45: 19–34.
Montastruc, JL, Senard, JM, Rascol, O, Rascol, A.Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences. Lab Pharmacol Med Clin 1996; 69: 377–81.
Pfeiffer, RF.Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease. Mov Disord 2010; 25 (Suppl 1): S94–7.
Oka, T, Yamamoto, H, Ohashi, N et al. Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography. Int J Cardiol 2012; 161: 45–9.
Barr, A, ed. The Shy–Drager syndrome. In Handbook of Clinical Neurology. New York, NY: Elsevier-North Holland; 1979.
Esper, CD, Factor, SA.Current and future treatments in multiple system atrophy. Curr Treat Options Neurol 2007; 9: 210–23.
Mayeux, RY, Stern, Y, Rosenstein, R et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 1988; 45: 260–2.
Mayeux, R, Stern, Y, Rosen, J, Leventhal, J.Depression, intellectual impairment, and Parkinson disease. Neurology 1981; 31: 645–50.
Cummings, JL.Managing psychosis in patients with Parkinson's disease. N Engl J Med 1999; 340: 801–3.
Dewey, RB, O'Suilleabhain, PE.Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2000; 55: 1753–4.
Friedman, JH, Factor, SA.Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000; 15: 201–11.
Paulson, GD, Tafrate, RH.Some “minor” aspects of parkinsonism, especially pulmonary function. Neurology 1970; 20: 14–17.
Mier, M.Mechanisms leading to hypoventilation in extrapyramidal disorders, with special reference to Parkinson's disease. J Am Geriatr Soc 1976; 15: 230–8.
Vincken, WG, Gauthier, SG, Dollfuss, RE et al. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 1984; 311: 438–42.
Irwin, RP, Nutt, JG, Woodward, WR, Gancher, ST.Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients. Clin Neuropharmacol 1992; 15: 365–74.
Pfeiffer, RF.Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 10–15.
Steele, JC.Progressive supranuclear palsy. Brain 1972; 95: 693–704.
Esper, CD, Weiner, WJ, Factor, SA.Progressive supranuclear palsy. Rev Neurol Dis 2007; 4: 209–16.
Folstein, MS, Folstein, SE, McHugh, PR.“Mini-mental state”. A practical method for grading the state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
Brod, TM.Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1989; 146: 1352–3.
Steur, EN.Increase of Parkinson disability after fluoxetine medication. Neurology 1993; 43: 211–13.
Sun-Edelstein, C, Tepper, SJ, Shapiro, RE.Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf 2008; 7: 587–96.
Fernandes, C, Reddy, P, Kessel, B.Rasagiline-induced serotonin syndrome. Mov Disord 2011; 26: 766–7.
Narayan, V, Haddad, PM.Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria. J Psychopharmacol 2011; 25: 306–13.
Hyman, SA, Rogers, WD, Smith, DW et al. Perioperative management for transplant of autologous adrenal medulla to the brain for parkinsonism. Anesthesiology 1988; 69: 618–22.
Lipowski, ZJ.Delirium in the elderly patient. N Engl J Med 1989; 320: 578–82.
Berry, P, Ward-Smith, PA.Adrenal medullary transplant as a treatment for Parkinson's disease: perioperative considerations. J Neurosci Nurs 1988; 20: 356–61.
Delgado, J, Billo, JM.Care of the patient with Parkinson's disease: surgical and nursing interventions. J Neurosci Nurs 1988; 20: 142–50.
Guze, BH, Baxer, LR. Neuroleptic malignant syndrome. N Engl J Med 1985; 313: 163.
Kaufman, CA.Neuroleptic malignant syndrome. In Meltzer, H, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987.
Frankel, JP, Lees, AJ, Kempster, PA, Stern, GM.Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53: 96–101.
Broussolle, E, Marion, MH, Pollak, P.Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery. Lancet 1992; 340(8823): 859–60.
Mitchelson, F.Pharmacological agents affecting emesis. A review (Part I). Drugs 1992; 43: 295–315.
Scuderi, P, Wetchler, B, Sung, YF et al. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology 1993; 78: 15–20.
Pfeiffer, RF, Kang, J, Graber, B, Hofman, R, Wilson, J.Clozapine for psychosis in Parkinson's disease. Mov Disord 1990; 5: 239–42.
Alvir, JM, Lieberman, JA, Safferman, AZ, Schwimmer, JL, Schaaf, JA.Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993; 329: 162–7.
Golden, WE, Lavender, RC, Metzer, WS.Acute postoperative confusion and hallucinations in Parkinson disease. Ann Intern Med 1989; 111: 218–22.
Ropper, AH.Neurological and Neurosurgical Intensive Care. New York, NY: Raven Press; 1993.
Galvez-Jimenez, N, Lang, AE.The perioperative management of Parkinson's disease revisited. Neurol Clin 2004; 22: 367–77.